Nafisi, Sara and Afsharirad, Bentelhoda and Khalili, Hossein and Hatamkhani, Shima (2022) Carnitine and its Derivatives as a Potential Option for Cardiovascular, Neurologic and Metabolic Complications of COVID-19. Journal of Pharmaceutical Research International, 34 (33A). pp. 48-56. ISSN 2456-9119
6271-Article Text-8447-2-10-20221006.pdf - Published Version
Download (386kB)
Abstract
As a multisystem disease, COVID-19 and its treatment demonstrate a wide variety of complications. Carnitine is a non-essential amino acid derivative that plays an essential role in the metabolism of fatty acids and alleviates inflammation and oxidative stress. We investigated the possible role of carnitine and its derivatives in COVID-19-induced fatigue, cardiovascular, neurological, and reproductive system complications. A thorough literature search was performed using the keywords and their synonym words including COVID-19, SARS-CoV-2, SARS, MERS, Carnitine, and L-Carnitine. Non-English literature and conference abstracts were not included. Animal experiments were excluded unless supporting the basic evidence for carnitine efficacy. Oxidative stress and Inflammatory factors are vital in cellular injury pathways caused by COVID-19. Carnitine and SARS-Cov-2 followed common cytokine and stress oxidative-related cellular pathways. Carnitine may act as a protective antioxidant against SARS-Cov-2 infection by modulating proinflammatory cytokines. Considering the safety profile of carnitine, it may have promising clinical results in alleviating COVID-19 severity and its complications.
Item Type: | Article |
---|---|
Subjects: | Journal Eprints > Medical Science |
Depositing User: | Managing Editor |
Date Deposited: | 17 Feb 2023 07:34 |
Last Modified: | 02 Jun 2024 07:30 |
URI: | http://repository.journal4submission.com/id/eprint/1339 |